← Leaderboards
Nicholas P Tatonetti
Columbia University Health Sciences
$8,220,679
Attributed
$12,496,837
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.7M · FY2014–25$5M$3.8M$2.5M$1.3M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,496,837 · 6
By mechanism
UG3$3,203,253 · 1
R35$2,753,784 · 1
OT3$2,740,096 · 1
R01$2,536,125 · 1
U24$864,044 · 1
R21$399,535 · 1
Top collaborators
- Michel Dumontier3 shared
- Chin Hur3 shared
- Chunhua Weng3 shared
- Jeanine M. Genkinger1 shared
- Jianhua Hu1 shared
- Konrad Karczewski1 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Donna R Shelley$27,358,680
- Atlas Khan$1,077,500
- Sandra Soo-Jin Lee$11,239,307
- Krzysztof Kiryluk$17,737,105
- Julian Abrams$10,470,386
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularResearch PersonnelPharmaceutical PreparationsElectronic Health RecordPathway InteractionsSafetyDrug InteractionsProgramsDesignAffectData AnalysesClinical TrialsPharmacologyData MiningVisionProspectiveBaseBiological ModelsInnovationAnimal ModelScienceProteinsLinkPathway Analysis
Grant awards (20)
PRISM: Ethically-guided multimodal AI models for predicting disease pathogenesis in individuals with pathogenic variants$3,203,253
UG3 · FY2025 · HG
Precision Pharmacology and Pharmacovigilance: Leveraging AI to address drug safety knowledge gaps$501,000
R35 · FY2025 · GM · contact PI
Data-driven drug discovery: investigating the molecular mechanisms of safety and efficacy$353,636
R35 · FY2023 · GM · contact PI
Coordinating Center for the Program on the Origins of Gastroesophageal Cancers$864,044
U24 · FY2022 · CA
Data-driven drug discovery: investigating the molecular mechanisms of safety and efficacy$247,160
R35 · FY2022 · GM · contact PI
Domain-Knowledge Informed Deep Learning for Early Detection of Pancreatic Cancer$222,661
R21 · FY2022 · CA
Data-driven drug discovery: investigating the molecular mechanisms of safety and efficacy$195,510
R35 · FY2022 · GM · contact PI
Data-driven drug discovery: investigating the molecular mechanisms of safety and efficacy$481,069
R35 · FY2021 · GM · contact PI
Domain-Knowledge Informed Deep Learning for Early Detection of Pancreatic Cancer$176,874
R21 · FY2021 · CA
Data-driven drug discovery: investigating the molecular mechanisms of safety and efficacy$13,271
R35 · FY2021 · GM · contact PI
Data-driven drug discovery: investigating the molecular mechanisms of safety and efficacy$481,069
R35 · FY2020 · GM · contact PI
Biomedical Data Translator Technical Feasibility Assessment and Architecture Design$702,655
OT3 · FY2019 · TR · contact PI
Data-driven drug discovery: investigating the molecular mechanisms of safety and efficacy$481,069
R35 · FY2019 · GM · contact PI
Biomedical Data Translator Technical Feasibility Assessment and Architecture Design$854,309
OT3 · FY2018 · TR · contact PI
Drug Effect Discovery Through Data Mining and Integrative Chemical Biology$484,645
R01 · FY2018 · GM · contact PI
Drug Effect Discovery Through Data Mining and Integrative Chemical Biology$484,645
R01 · FY2017 · GM · contact PI
Biomedical Data Translator Technical Feasibility Assessment and Architecture Design$1,183,132
OT3 · FY2016 · TR · contact PI
Drug Effect Discovery Through Data Mining and Integrative Chemical Biology$484,645
R01 · FY2016 · GM · contact PI
Drug Effect Discovery Through Data Mining and Integrative Chemical Biology$484,645
R01 · FY2015 · GM · contact PI
Drug Effect Discovery Through Data Mining and Integrative Chemical Biology$597,545
R01 · FY2014 · GM · contact PI